Tag: Sun Pharmaceutical Industries
Sun Pharmaceutical gets SEZABY FDA approval for neonatal seizures
Sun Pharmaceutical Industries has secured approval for SEZABY (phenobarbital sodium powder for injection) from the US Food and Drug Administration (FDA) for the treatment of ... Read More
Sun Pharmaceutical subsidiary acquires Alchemee business from Galderma
Sun Pharmaceutical Industries said that its subsidiary Taro Pharmaceutical Industries’ fully-owned subsidiary Taro Pharmaceuticals U.S.A., has acquired Delaware-based Galderma Holdings, Japan-based Proactiv YK, Canada-based The ... Read More
Sun Pharmaceutical wins FDA approval for generic Amphotericin B Liposome
Sun Pharmaceutical Industries said that one of its fully-owned subsidiaries has secured final approval from the US Food and Drug Administration (FDA) for its abbreviated ... Read More
Sun Pharma launches Revital NXT nutrition bar in India
Sun Pharma Consumer Healthcare, a unit of Sun Pharmaceutical Industries (Sun Pharma), has made its entry into the nutrition bar segment in India through the ... Read More
Cipla, Dr. Reddy’s, and others to collaborate on Molnupiravir Covid trial
Five Indian pharma companies – Cipla, Dr. Reddy’s Laboratories, Emcure Pharmaceuticals, Sun Pharmaceutical Industries, and Torrent Pharmaceuticals will join forces to undertake a clinical trial ... Read More
Sun Pharma to settle patent litigation with Celgene for generic Revlimid
Sun Pharmaceutical Industries (Sun Pharma) along with one of its fully-owned subsidiaries has reached an agreement with Celgene, a fully-owned subsidiary of Bristol Myers Squibb, ... Read More
Sun Pharma signs licensing deal with Lilly for Covid-19 drug baricitinib
Sun Pharmaceutical Industries (Sun Pharma) said that it has signed a royalty-free, non-exclusive voluntary licensing agreement with Eli Lilly and Company for expanding access to ... Read More
Sun Pharma announces CEQUA FDA approval for dry eye treatment
CEQUA FDA approval : Sun Pharmaceutical Industries has secured approval for CEQUA (cyclosporine ophthalmic solution) 0.09%, from the US Food and Drug Administration (FDA) to ... Read More